Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does butein affect adipogenesis?

Adipocyte·2019
Same author

ADAMTS5 deficiency in mice does not affect cardiac function.

Cell biology international·2019
Same author

Advanced-age C57BL/6JRj mice do not develop obesity upon western-type diet exposure.

Adipocyte·2019
Same author

Deficiency of Bmal1 disrupts the diurnal rhythm of haemostasis.

Experimental gerontology·2019
Same author

Monitoring reperfused myocardial infarction with delayed left ventricular systolic dysfunction in rabbits by longitudinal imaging.

Quantitative imaging in medicine and surgery·2018
Same author

Adiposity and metabolic health in mice deficient in intestinal alkaline phosphatase.

Adipocyte·2018

Related Experiment Video

Updated: Jul 10, 2026

Co-staining Blood Vessels and Nerve Fibers in Adipose Tissue
12:05

Co-staining Blood Vessels and Nerve Fibers in Adipose Tissue

Published on: February 13, 2019

Angiogenesis and obesity.

H Roger Lijnen1

  • 1Center for Molecular and Vascular Biology, KU Leuven, Campus Gasthuisberg, O & N 1, Herestraat 49, Box 911, 3000 Leuven, Belgium. roger.lijnen@med.kuleuven.be

Cardiovascular Research
|November 17, 2007
PubMed
Summary
This summary is machine-generated.

Obesity development involves changes in adipose tissue, including cell growth and blood vessel formation. Proteolytic systems are key, and their disruption may hinder healthy adipose tissue development.

More Related Videos

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

Related Experiment Videos

Last Updated: Jul 10, 2026

Co-staining Blood Vessels and Nerve Fibers in Adipose Tissue
12:05

Co-staining Blood Vessels and Nerve Fibers in Adipose Tissue

Published on: February 13, 2019

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

Area of Science:

  • Biochemistry
  • Cell Biology
  • Physiology

Background:

  • Obesity development involves significant changes in adipose tissue structure.
  • Key processes include adipogenesis, angiogenesis, and extracellular matrix remodeling.
  • These processes rely on proteolytic systems like fibrinolytic, MMP, and ADAM/ADAMTS.

Purpose of the Study:

  • To explore the role of proteolytic systems in adipose tissue development.
  • To understand the interplay between angiogenesis and adipogenesis.
  • To investigate how modulating these systems might affect adipose tissue formation.

Main Methods:

  • Analysis of adipose tissue explants.
  • Investigation of endothelial cell-mediated pre-adipocyte differentiation.
  • Examination of the impact of angiogenesis and proteolytic system modulation.

Main Results:

  • Adipogenesis is closely linked with angiogenesis in early adipose tissue development.
  • Adipose tissue explants stimulate blood vessel formation.
  • Adipose tissue endothelial cells promote pre-adipocyte differentiation.

Conclusions:

  • Proteolytic systems are crucial for adipose tissue development.
  • The interaction between angiogenesis and adipogenesis is vital.
  • Disruption of angiogenesis or proteolytic systems can impair adipose tissue development, potentially contributing to obesity.